Jubilant Pharmova announces that its wholly-owned subsidiary, Jubilant Biosys Limited, has received a GST demand order. The order, issued by the Joint Commissioner Noida, confirms a GST demand of ₹6.98 crore and a penalty of ₹2.72 crore for the financial years 2020-21, 2021-22, and 2022-23. The company is planning to file an appeal against the order.
GST Demand Details
Jubilant Pharmova’s subsidiary, Jubilant Biosys Limited, has received an order dated December 24, 2025, confirming a GST demand along with penalties. The demand order, issued by the Joint Commissioner, pertains to alleged discrepancies in availing GST input tax credit for the financial years 2020-21, 2021-22, and 2022-23.
Financial Implications and Response
The confirmed GST demand amounts to ₹6.98 crore, with an additional penalty of ₹2.72 crore, bringing the total claim to ₹9.71 crore. Jubilant Pharmova believes the demand is legally incorrect and intends to file an appeal before the Commissioner (Appeals). The company does not anticipate any material impact on its financials or operations as a result of this demand.
Source: BSE
